Compare LACTOSE INDIA with INWINEX PHARMA. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs SOURCE NATURAL FOODS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA SOURCE NATURAL FOODS LACTOSE INDIA/
SOURCE NATURAL FOODS
 
P/E (TTM) x -85.2 25.5 - View Chart
P/BV x 1.3 5.5 23.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LACTOSE INDIA   SOURCE NATURAL FOODS
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-21
SOURCE NATURAL FOODS
Mar-21
LACTOSE INDIA/
SOURCE NATURAL FOODS
5-Yr Chart
Click to enlarge
High Rs42189 22.1%   
Low Rs1646 34.8%   
Sales per share (Unadj.) Rs30.635.0 87.2%  
Earnings per share (Unadj.) Rs-2.25.2 -41.3%  
Cash flow per share (Unadj.) Rs1.65.8 28.3%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs30.120.4 147.5%  
Shares outstanding (eoy) m11.446.44 177.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.93.4 28.2%   
Avg P/E ratio x-13.322.4 -59.5%  
P/CF ratio (eoy) x17.620.2 86.9%  
Price / Book Value ratio x1.05.7 16.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m330756 43.7%   
No. of employees `000NANA-   
Total wages/salary Rs m10624 439.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m350226 154.9%  
Other income Rs m33 92.1%   
Total revenues Rs m353229 154.0%   
Gross profit Rs m6242 147.4%  
Depreciation Rs m444 1,184.2%   
Interest Rs m542 3,342.3%   
Profit before tax Rs m-3340 -81.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-87 -120.5%   
Profit after tax Rs m-2534 -73.4%  
Gross profit margin %17.818.7 95.1%  
Effective tax rate %24.216.3 148.7%   
Net profit margin %-7.114.9 -47.4%  
BALANCE SHEET DATA
Current assets Rs m197111 178.0%   
Current liabilities Rs m11637 315.7%   
Net working cap to sales %23.132.7 70.6%  
Current ratio x1.73.0 56.4%  
Inventory Days Days597 854.8%  
Debtors Days Days67196,787,686 0.0%  
Net fixed assets Rs m68646 1,479.7%   
Share capital Rs m11464 177.7%   
"Free" reserves Rs m23067 342.7%   
Net worth Rs m345132 262.0%   
Long term debt Rs m3930 151,019.2%   
Total assets Rs m883157 562.3%  
Interest coverage x0.425.7 1.6%   
Debt to equity ratio x1.10 57,644.4%  
Sales to assets ratio x0.41.4 27.5%   
Return on assets %3.422.5 14.9%  
Return on equity %-7.225.6 -28.0%  
Return on capital %3.031.8 9.3%  
Exports to sales %00-   
Imports to sales %7.40-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m26NA-   
Fx inflow Rs m250-   
Fx outflow Rs m270-   
Net fx Rs m-20-   
CASH FLOW
From Operations Rs m2245 48.5%  
From Investments Rs m-62-20 301.6%  
From Financial Activity Rs m453 1,627.3%  
Net Cashflow Rs m527 19.0%  

Share Holding

Indian Promoters % 49.1 74.4 66.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.7 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.9 25.6 198.5%  
Shareholders   15,737 3,087 509.8%  
Pledged promoter(s) holding % 47.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   MESCO PHARMA  ABBOTT INDIA  DIVIS LABORATORIES  PFIZER  KILITCH DRUGS  



Today's Market

Sensex Jumps 550 Points, Nifty Above 17,000; Metal & Banking Stocks Rally(10:30 am)

Asian stock markets are higher today as investors took heart from strong rebounds on Wall Street on hopes that the newest coronavirus variant will prove less virulent than earlier strains.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LACTOSE INDIA SHARE PRICE


Dec 7, 2021 11:29 AM

TRACK LACTOSE INDIA

  • Track your investment in LACTOSE INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LACTOSE INDIA 5-YR ANALYSIS

COMPARE LACTOSE INDIA WITH

MARKET STATS